Cencora Price to Book Ratio 2010-2025 | COR
Historical price to book ratio values for Cencora (COR) over the last 10 years. The current price to book ratio for Cencora as of May 09, 2025 is 46.64.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Cencora Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-09 | 283.00 | 46.48 | |
| 2025-03-31 | 278.09 | $6.09 | 45.68 |
| 2024-12-31 | 224.18 | $1.87 | 120.08 |
| 2024-09-30 | 224.07 | $4.04 | 55.52 |
| 2024-06-30 | 223.80 | $5.38 | 41.58 |
| 2024-03-31 | 240.83 | $6.15 | 39.13 |
| 2023-12-31 | 203.11 | $5.32 | 38.18 |
| 2023-09-30 | 177.52 | $3.32 | 53.50 |
| 2023-06-30 | 189.32 | $4.56 | 41.50 |
| 2023-03-31 | 157.07 | $2.53 | 62.20 |
| 2022-12-31 | 162.06 | $0.36 | 445.60 |
| 2022-09-30 | 131.95 | $0.35 | 381.79 |
| 2022-06-30 | 137.52 | $2.49 | 55.20 |
| 2022-03-31 | 149.92 | $4.33 | 34.65 |
| 2021-12-31 | 128.36 | $2.88 | 44.64 |
| 2021-09-30 | 114.95 | $2.81 | 40.93 |
| 2021-06-30 | 109.78 | $1.97 | 55.83 |
| 2021-03-31 | 112.79 | $-0.50 | -225.31 |
| 2020-12-31 | 93.00 | $-2.50 | -37.21 |
| 2020-09-30 | 91.82 | $-4.11 | -22.33 |
| 2020-06-30 | 95.08 | $19.45 | 4.89 |
| 2020-03-31 | 83.08 | $18.22 | 4.56 |
| 2019-12-31 | 79.47 | $14.91 | 5.33 |
| 2019-09-30 | 76.59 | $14.48 | 5.29 |
| 2019-06-30 | 78.95 | $14.91 | 5.29 |
| 2019-03-31 | 73.26 | $14.46 | 5.07 |
| 2018-12-31 | 68.22 | $15.00 | 4.55 |
| 2018-09-30 | 84.18 | $14.30 | 5.89 |
| 2018-06-30 | 77.50 | $15.10 | 5.13 |
| 2018-03-31 | 78.01 | $15.31 | 5.10 |
| 2017-12-31 | 82.76 | $13.16 | 6.29 |
| 2017-09-30 | 74.24 | $9.47 | 7.84 |
| 2017-06-30 | 84.42 | $11.66 | 7.24 |
| 2017-03-31 | 78.70 | $11.59 | 6.79 |
| 2016-12-31 | 69.25 | $9.75 | 7.10 |
| 2016-09-30 | 71.21 | $9.68 | 7.36 |
| 2016-06-30 | 69.66 | $8.76 | 7.96 |
| 2016-03-31 | 75.66 | $9.78 | 7.74 |
| 2015-12-31 | 90.31 | $6.30 | 14.33 |
| 2015-09-30 | 82.44 | $2.98 | 27.67 |
| 2015-06-30 | 92.03 | $7.28 | 12.65 |
| 2015-03-31 | 98.12 | $8.67 | 11.32 |
| 2014-12-31 | 77.60 | $8.06 | 9.63 |
| 2014-09-30 | 66.31 | $8.82 | 7.52 |
| 2014-06-30 | 62.14 | $8.86 | 7.02 |
| 2014-03-31 | 55.90 | $9.43 | 5.93 |
| 2013-12-31 | 59.71 | $9.75 | 6.12 |
| 2013-09-30 | 51.71 | $10.09 | 5.13 |
| 2013-06-30 | 47.08 | $10.48 | 4.49 |
| 2013-03-31 | 43.22 | $10.16 | 4.25 |
| 2012-12-31 | 36.11 | $10.17 | 3.55 |
| 2012-09-30 | 32.21 | $10.43 | 3.09 |
| 2012-06-30 | 32.62 | $11.66 | 2.80 |
| 2012-03-31 | 32.77 | $11.54 | 2.84 |
| 2011-12-31 | 30.62 | $11.24 | 2.72 |
| 2011-09-30 | 30.58 | $10.98 | 2.78 |
| 2011-06-30 | 33.87 | $11.77 | 2.88 |
| 2011-03-31 | 32.27 | $11.45 | 2.82 |
| 2010-12-31 | 27.76 | $10.82 | 2.57 |
| 2010-09-30 | 24.86 | $10.65 | 2.34 |
| 2010-06-30 | 25.68 | $10.42 | 2.46 |
| 2010-03-31 | 23.33 | $10.06 | 2.32 |
| 2009-12-31 | 20.97 | $9.66 | 2.17 |
| 2009-09-30 | 17.94 | $9.43 | 1.90 |
| 2009-06-30 | 14.18 | $9.37 | 1.51 |
| 2009-03-31 | 13.02 | $9.14 | 1.42 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $55.028B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.427B | 26.15 |
| Elevance Health (ELV) | United States | $93.171B | 12.02 |
| CVS Health (CVS) | United States | $85.832B | 10.67 |
| Natera (NTRA) | United States | $21.977B | 0.00 |
| DiDi Global (DIDIY) | China | $20.426B | 31.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
| Solventum (SOLV) | United States | $11.527B | 12.20 |
| CochLear (CHEOY) | Australia | $11.409B | 0.00 |
| ICON (ICLR) | Ireland | $11.183B | 10.40 |
| Doximity (DOCS) | United States | $11.080B | 57.62 |
| Revvity (RVTY) | United States | $10.950B | 18.84 |
| Viatris (VTRS) | United States | $10.779B | 3.67 |
| Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
| Avantor (AVTR) | United States | $8.368B | 12.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.900B | 38.86 |
| Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
| Sotera Health (SHC) | United States | $3.755B | 21.34 |
| Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.907B | 33.35 |
| Concentras Parent (CON) | United States | $2.706B | 15.64 |
| Organon (OGN) | United States | $2.345B | 2.49 |
| Premier (PINC) | United States | $2.127B | 14.56 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
| Progyny (PGNY) | United States | $2.002B | 44.09 |
| GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
| Agilon Health (AGL) | United States | $1.333B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
| CareDx (CDNA) | United States | $0.857B | 13.38 |
| AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
| Embecta (EMBC) | United States | $0.773B | 5.30 |
| QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Enhabit (EHAB) | United States | $0.491B | 40.38 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| LifeMD (LFMD) | United States | $0.371B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.336B | 0.00 |
| DocGo (DCGO) | United States | $0.238B | 38.83 |
| Oncology Institute (TOI) | United States | $0.221B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
| Beauty Health (SKIN) | United States | $0.155B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |